Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 2 selected

Type

Guidance programme

Showing 1951 to 2000 of 2210

TitleReference numberPublishedLast updated
Temsirolimus for the treatment of relapsed or refractory mantle cell lymphoma (terminated appraisal)TA207
Tenecteplase for treating acute ischaemic strokeTA990
Tenofovir alafenamide for treating chronic hepatitis B (terminated appraisal)TA435
Tenofovir disoproxil for the treatment of chronic hepatitis BTA173
Tenotomy of horizontal eye muscles for nystagmus (with reattachment at their original insertions)HTG191
Tepotinib for treating advanced non-small-cell lung cancer with MET gene alterationsTA789
Teriflunomide for treating relapsing–remitting multiple sclerosisTA303
Testing strategies for Lynch syndrome in people with endometrial cancerHTG557
Tests in secondary care to identify people at high risk of ovarian cancerHTG453
Tests to help assess risk of acute kidney injury for people being considered for critical care admission (ARCHITECT and Alinity i Urine NGAL assays, BioPorto NGAL test and NephroCheck test)HTG544
Tezepelumab for treating severe asthmaTA880
The Debrisoft monofilament debridement pad for use in acute or chronic woundsHTG334
The EOS 2D/3D imaging systemHTG274
The geko device for reducing the risk of venous thromboembolismHTG344
The MIST Therapy system for the promotion of wound healingHTG267
The PLASMA system for transurethral resection and haemostasis of the prostateHTG563
The ReCell Spray‑On Skin system for treating skin loss, scarring and depigmentation after burn injuryHTG356
The Sherlock 3CG Tip Confirmation System for placement of peripherally inserted central cathetersHTG368
The VAC Veraflo Therapy system for acute infected or chronic wounds that are failing to healHTG566
Therapeutic amnioinfusion for oligohydramnios during pregnancy (excluding labour)HTG124
Therapeutic endoscopic division of epidural adhesionsHTG210
Therapeutic hypothermia for acute ischaemic strokeHTG511
Therapeutic hypothermia with intracorporeal temperature monitoring for hypoxic perinatal brain injuryHTG221
Therapeutic monitoring of TNF-alpha inhibitors in Crohn's disease (LISA-TRACKER ELISA kits, IDKmonitor ELISA kits, and Promonitor ELISA kits)HTG401
Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritisHTG521
Therapeutic percutaneous image-guided aspiration of spinal cystsHTG143
Therapeutic sialendoscopyHTG140
Thopaz+ portable digital system for managing chest drainsHTG465
Thoracoscopic aortopexy for severe primary tracheomalaciaHTG156
Thoracoscopic epicardial radiofrequency ablation for atrial fibrillationHTG180
Thoracoscopic excision of mediastinal parathyroid tumoursHTG159
Thoracoscopic exclusion of the left atrial appendage (with or without surgical ablation) for non-valvular atrial fibrillation for the prevention of thromboembolismHTG266
Thoracoscopic repair of congenital diaphragmatic hernia in neonatesHTG247
Thoracoscopically assisted mitral valve surgeryHTG157
Thrombin injections for pseudoaneurysmsHTG33
Thyroid cancer: assessment and managementNG230
Thyroid disease: assessment and managementNG145
Ticagrelor for preventing atherothrombotic events after myocardial infarctionTA420
Ticagrelor for the treatment of acute coronary syndromesTA236
Tildrakizumab for treating moderate to severe plaque psoriasisTA575
Tinnitus: assessment and managementNG155
Tirzepatide for managing overweight and obesityTA1026
Tirzepatide for treating type 2 diabetesTA924
Tisagenlecleucel for treating follicular lymphoma after 2 or more therapies (terminated appraisal)TA842
Tisagenlecleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people 25 years and underTA975
Tisagenlecleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic therapies (terminated appraisal)TA933
Tislelizumab for treating advanced non-small-cell lung cancer after platinum-based chemotherapy (terminated appraisal)TA1072
Tislelizumab for treating unresectable advanced oesophageal squamous cell cancer after platinum-based chemotherapy (terminated appraisal)TA1068
Tislelizumab in combination for untreated advanced non-small-cell lung cancer (terminated appraisal)TA1058
Tissue-cultured limbal stem cell allograft transplantation for regrowth of corneal epitheliumHTG139

Results per page

  1. 10
  2. 25
  3. 50
  4. All